Antibiotics: Skin infections and the FDA approval of Baxdela
by Robert Herriman from Outbreak News Today on (#2VD4M)
The Food and Drug Administration recently approved a new antibiotic into the arsenal for treating serious acute bacterial skin and skin structure infections (ABSSSI). Its called delafloxacin and goes by the trade name, Baxdela and its manufactured by Melinta Therapeutics. Assistant Professor of Medicine, David Geffen School of Medicine at UCLA, James McKinnell, M.D. joined me ["]
The post Antibiotics: Skin infections and the FDA approval of Baxdela appeared first on Outbreak News Today.